SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- May 30, 2007 -- Holmes Biopharma, Inc. (PINK SHEETS: HLMB) announces that sales for its Phase 1 clinical research facility have grown by approximately 3000% since opening in December 2006, now reaching $6 million dollars in committed contracts.
